CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Medmira Inc. Company Snapshot
Medmira Inc. operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Medmira Inc. with three other pharmaceutical manufacturers in North America: Navidea Biopharmaceuticals Incorporated of UNITED STATES (2019 sales of $657,826.00 of which 63% was Diagnostics), Immunomedics, Inc. of UNITED STATES ($295,000.00 of which 100% was Biopharma Products), and Nymox Pharmaceutical Corp (153,490.04 Canadian Dollars [US$116,457.50 ] of which 100% was research and development).

Sales Analysis. Medmira Inc. reported sales of C$527,445.00 (US$400.19 thousand) for the fiscal year ending July of 2019. This represents a decrease of 10.4% versus 2018, when the company's sales were C$588,871.00 .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Medmira Inc.
  Stock Performance Chart for Medmira Inc.
 
  Stock Data: Recent Stock Performance:
  Current Price (9/11/2020): .34
(Figures in Canadian Dollars)
1 Week -10.7%   13 Weeks -15.2%  
4 Weeks -31.6%   52 Weeks 6,600.0%  
 
Medmira Inc. Key Data:
  Ticker: MIR Country: Canada
  Exchanges: VEN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2019 Sales 527,445
(Year Ending Jan 2020).
Employees: N/A
  Currency: Canadian Dollars Market Cap: 220,552,047
  Fiscal Yr Ends: July Shares Outstanding: 658,364,320
  Share Type: Common Closely Held Shares: 476,912,500
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.